A Prospective Cohort Study of Combined Subinguinal Varicocele Ligation and Sclerotherapy

ConditionVaricocele
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University

About this trial

Traditional surgical ligation of the spermatic cord veins is effective in reducing the size of the varicocele and improving fertility outcomes. However, this procedure can be associated with complications such as hydrocele formation and recurrence . Antegrade sclerotherapy offers a minimally invasive alternative, involving the injection of a sclerosing agent directly into the dilated veins to achieve occlusion and reduce reflux .

This study aims to optimize treatment outcomes for varicocele by combining the benefits of surgical ligation with the sclerosing effects of sclerotherapy .The primary goal is to evaluate the efficacy and safety of combining antegrade sclerotherapy and surgical ligation in the treatment of varicocele .

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1- Clinically and Doppler confirmed grades II or III varicocele. 2- All left, right or bilateral side varicocele. 3- Testicular pain or testicular atrophy. 4- Presence of at least one impaired semen parameter. 5- Age more than 18years

Disqualifiers

1- Pre-existing hydrocele. 2- Concomitant hernia 3- Previous inguinal surgery

Trial population

varicocele patients withClinically and Doppler confirmed grades II or III varicocele.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

22 Participants
are grouped into 1 trial group
Group A: varicocel patients

Trial outcomes

Primary outcomes

1

varicocele grade

Assess the change in varicocele grade from baseline to post-treatment using clinical examination and/or ultrasound

Time frame
30 day

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: